Background {#Sec1}
==========

The association between case volume and patient outcome in complex surgical procedures have been reported consistently \[[@CR1]--[@CR3]\]. The mechanism behind the relationship is unclear but proposed explanations include accumulated experience at the individual or institutional level and preferential referral, which in turn may lead to increased case volume and improved outcomes. Numerous reports regarding the inverse relationship between case volume and postoperative mortality after high-risk procedures have led to debates/discussions concerning regionalization or efficient allocation of medical resources \[[@CR4]--[@CR8]\].

Thoracic aorta replacement surgery is one of the most complex surgical procedures requiring meticulous perioperative care with a reported 30-day mortality rate ranging from 5 to 10% \[[@CR9], [@CR10]\]. Moreover, serious postoperative complications including paraplegia or stroke are not uncommon, and thus, there is still room for improvement in patient outcomes despite recent improvement \[[@CR10], [@CR11]\]. Institutions with higher volume or more experience are likely to have a system or protocol regarding high-risk surgical procedures and the management thereafter \[[@CR1]\]. However, the impact of institutional case volume in thoracic aorta replacement surgery on patient outcome has not been evaluated.

The aim of the study was to determine the relationship between institutional case volume and postoperative mortality in patients undergoing thoracic aorta replacement surgery. A population-based, retrospective observational study was performed by analyzing the National Health Insurance Service (NHIS) database in Korea to evaluate the case volume effect in thoracic aorta replacement surgery.

Methods {#Sec2}
=======

The study design was a nationwide population-based retrospective observational study. The study protocol was determined exempt from review by the Institutional Review Board of Seoul National University Hospital due to the retrospective study design and the de-identified nature of the database.

Study population and data collection {#Sec3}
------------------------------------

Data from the NHIS database which covers more than 97% of Koreans was used for analysis \[[@CR12], [@CR13]\]. All adult cases of isolated thoracic aorta replacement surgery performed between January 2009 and December 2016 in Korea were analyzed using the procedure codes for ascending aorta, aortic arch, and descending thoracic aorta replacement surgeries. Preoperative comorbidities were identified using the International Classification of Diseases, 10th revision (ICD-10) codes. Codes for emergent surgery and perioperative red blood cell transfusion were also extracted from the NHIS database. In-hospital, 1-year, and cumulative all-cause mortality were also collected. The institutional case volume was defined as the annual average number of thoracic aorta replacement surgeries performed during the study period. Centers were classified as low (\< 30 cases/year), medium (30--60 cases/year), or high volume centers (\> 60 cases/year) according to case volume of the center.

Study endpoints and statistical analysis {#Sec4}
----------------------------------------

The primary outcome was in-hospital mortality after thoracic aorta replacement surgery according to the institutional case volume. Secondary outcomes included 1-year mortality and cumulative all-cause mortality.

Continuous data were expressed as mean (standard deviation) or median (interquartile range) where appropriate and categorical data as number (%). To compare patient characteristics and preoperative comorbidities, the one-way analysis of variance or the Kruskal-Wallis test was used for continuous variables and the χ^2^ test for categorical variables.

Logistic regression was performed to analyze the risk of in-hospital and 1-year mortality. Multivariable logistic regression was performed to adjust for extracted relevant variables including patient characteristics, preoperative comorbidities, and the year of surgery without applying any variable selection method. The amount of perioperative red blood cell transfusion was categorized: 0--1, 2--3, 4--5, and ≥ 6 units.

Cox proportional hazards model was used to compare the risk of cumulative all-cause mortality according to institutional case volume. The log-minus-log plot was used to check whether the proportional hazards assumption was met. Kaplan-Meier survival curves were also plotted.

All analyses were performed using SAS (ver. 9.4; SAS Institute, Cary, NC) and R (ver. 3.6.1; R Development Core Team, Vienna, Austria). A *P* value under 0.05 was considered statistically significant.

Results {#Sec5}
=======

Overall, 4867 cases of thoracic aorta replacement surgery were performed across 83 centers in Korea between January 2009 and December 2016. Thoracic aorta replacement surgery was performed on 1928 patients in 72 low volume centers, 717 patients in 5 medium volume centers, and 2222 in 6 high volume centers. Baseline characteristics according to case volume strata are presented in Table [1](#Tab1){ref-type="table"}. Patients in high volume centers were older and had higher rate of comorbidities such as hypertension, hyperlipidemia, diabetes, and atrial fibrillation compared to patients in low and medium volume centers. In addition, descending thoracic aorta replacement and combined (2 or more of the 3 segments) thoracic aorta replacement were more frequently performed in high volume centers compared to lower volume centers (Table [1](#Tab1){ref-type="table"}). Table 1Patient characteristics and preoperative comorbidities according to case volumeLow volume\
(\< 30 cases/year, *n* = 1928)Medium volume\
(30--60 cases/year, *n* = 717)High volume\
(\> 60 cases/year, *n* = 2222)*P*Age (years)61.9 (14.4)60.6 (14.7)63.2 (13.3)\< 0.001Female969 (50.3%)340 (47.4%)844 (38.0%)\< 0.001Extracardiac arteriopathy250 (13.0%)77 (10.7%)298 (13.4%)0.174Renal impairment31 (1.6%)7 (1.0%)29 (1.3%)0.430Chronic lung disease623 (32.3%)239 (33.3%)745 (33.5%)0.695Hypertension1151 (59.7%)397 (55.4%)1446 (65.1%)\< 0.001Hyperlipidemia382 (19.8%)154 (21.5%)618 (27.8%)\< 0.001Diabetes mellitus150 (7.8%)42 (5.9%)193 (8.7%)0.049Atrial fibrillation66 (3.4%)26 (3.6%)133 (6.0%)\< 0.001Angina pectoris351 (18.2%)154 (21.5%)521 (23.5%)\< 0.001Recent MI42 (2.2%)7 (1.0%)37 (1.7%)0.101History of PCI15 (0.8%)8 (1.1%)26 (1.2%)0.429Congestive heart failure157 (8.1%)69 (9.6%)180 (8.1%)0.405Emergent surgery104 (5.4%)27 (3.8%)70 (3.2%)0.001Perioperative RBC Transfusion (units)4 (3--5)3 (2--4)3 (2--5)\< 0.001Surgery site\< 0.001 Ascending aorta805 (41.8%)312 (43.5%)330 (14.9%) Aortic arch185 (9.6%)30 (4.2%)81 (3.7%) Descending thoracic aorta283 (14.7%)144 (20.1%)672 (30.2%) Combined655 (34.0%)231 (32.2%)1139 (51.3%)Data are presented as number (%), mean (standard deviation), or median (interquartile range)*MI* Myocardial infarction, *PCI* Percutaneous coronary intervention, *RBC* Red blood cell

In-hospital mortality {#Sec6}
---------------------

The overall in-hospital mortality was 14.2% (690/4867). The in-hospital mortality in high, medium, and low volume centers were 8.6% (191/2222), 10.7% (77/717), and 21.9% (422/1928), respectively. Figure [1](#Fig1){ref-type="fig"}a shows the in-hospital mortality of each center based on their case volume. The risk of in-hospital mortality was significantly higher in the medium (the adjusted odds ratio \[OR\], 1.56; 95% confidence interval \[CI\], 1.16--2.11, *P* = 0.004) and low volume centers (the adjusted OR, 3.12; 95% CI, 2.54--3.85, *P* \< 0.001) compared to high volume centers (Table [2](#Tab2){ref-type="table"}). Fig. 1(**a**) In-hospital and (**b**) 1-year mortality after thoracic aorta replacement according to institutional case volumeTable 2Logistic regression for in-hospital mortality after thoracic aorta replacement surgeryUnivariable modelMultivariable modelOR \[95% CI\]*P*OR \[95% CI\]*P*Case volume strata High volume (\> 60 cases/year)ReferenceReference Medium volume (30--60 cases/year)1.28 \[0.97--1.69\]0.0841.56 \[1.16--2.11\]0.004 Low volume (\< 30 cases/year)2.98 \[2.48--3.58\]\< 0.0013.12 \[2.54--3.85\]\< 0.001Age ≤ 49ReferenceReference 50--591.11 \[0.82--1.52\]0.5021.14 \[0.82--1.58\]0.449 60--691.51 \[1.15--1.97\]0.0031.51 \[1.12--2.03\]0.008 70--792.17 \[1.68--2.79\]\< 0.0012.21 \[1.64--2.99\]\< 0.001 ≥ 802.69 \[1.92--3.76\]\< 0.0013.30 \[2.25--4.85\]\< 0.001Female1.02 \[0.87--1.20\]0.8190.80 \[0.66--0.97\]0.021Extracardiac arteriopathy1.30 \[1.03--1.62\]0.0241.08 \[0.84--1.39\]0.559Renal impairment3.46 \[2.09--5.75\]\< 0.0011.88 \[1.07--3.33\]0.029Chronic lung disease1.21 \[1.02--1.43\]0.0280.96 \[0.79--1.16\]0.649Hypertension1.19 \[1.01--1.41\]0.0380.89 \[0.72--1.09\]0.262Hyperlipidemia1.14 \[0.95--1.37\]0.1641.03 \[0.83--1.29\]0.776Diabetes1.33 \[1.01--1.75\]0.0421.01 \[0.74--1.38\]0.933Angina pectoris1.25 \[1.03--1.50\]0.0231.12 \[0.89--1.39\]0.342Recent MI1.51 \[0.88--2.58\]0.1351.19 \[0.66--2.14\]0.560History of PCI2.45 \[1.31--4.58\]0.0051.64 \[0.80--3.39\]0.181Congestive heart failure1.42 \[1.09--1.85\]0.0101.13 \[0.83--1.53\]0.428Emergent surgery2.02 \[1.45--2.82\]\< 0.0011.58 \[1.09--2.31\]0.017Atrial fibrillation1.46 \[1.04--2.06\]0.0301.30 \[0.89--1.90\]0.181Perioperative RBC Transfusion 0--1 unitsReferenceReference 2--3 units2.51 \[1.27--4.95\]0.0081.98 \[0.99--3.96\]0.053 4--5 units5.25 \[2.65--10.38\]\< 0.0013.71 \[1.86--7.43\]\< 0.001 ≥ 6 units16.51 \[8.39--32.47\]\< 0.00111.44 \[5.75--22.79\]\< 0.001Surgery site Ascending aortaReferenceReference Aortic arch1.89 \[1.39--2.56\]\< 0.0011.55 \[1.10--2.17\]0.012 Descending thoracic aorta1.07 \[0.86--1.33\]0.5581.25 \[0.96--1.63\]0.091 Combined0.87 \[0.71--1.06\]0.1551.03 \[0.82--1.29\]0.814Surgery year0.98 \[0.94--1.01\]0.2000.98 \[0.94--1.02\]0.218*CI* Confidence interval, *MI* Myocardial infarction, *OR* Odds ratio, *PCI* Percutaneous coronary intervention, *RBC* Red blood cell

One year mortality {#Sec7}
------------------

The overall 1 year mortality rate after thoracic aorta replacement surgery was 19.7% (960/ 4867). One year mortality was 14.0% (312/2222), 15.5% (111/717), and 27.9% (537/1928) in high, medium, and low volume centers, respectively. The distribution of 1 year mortality according to institutional case volume are shown in Fig. [1](#Fig1){ref-type="fig"}b. Compared to high volume center, the adjusted OR of 1-year mortality in medium volume center was 1.45 (95% CI, 1.12--1.87; *P* = 0.005; Table [3](#Tab3){ref-type="table"}). In low volume center, the adjusted OR was 2.62 (95% CI, 2.18--3.14; *P* \< 0.001; Table [3](#Tab3){ref-type="table"}). Table 3Logistic regression for 1-year mortality after thoracic aorta replacement surgeryUnivariable modelMultivariable modelOR \[95% CI\]*P*OR \[95% CI\]*P*Case volume strata High volume (\> 60 cases/year)ReferenceReference Medium volume (30--60 cases/year)1.12 \[0.89--1.42\]0.3401.45 \[1.12--1.87\]0.005 Low volume (\< 30 cases/year)2.36 \[2.02--2.76\]\< 0.0012.62 \[2.18--3.14\]\< 0.001Age ≤ 49ReferenceReference 50--591.16 \[0.88--1.53\]0.2781.23 \[0.92--1.65\]0.168 60--691.63 \[1.29--2.08\]\< 0.0011.72 \[1.32--2.25\]\< 0.001 70--792.53 \[2.02--3.16\]\< 0.0012.81 \[2.15--3.68\]\< 0.001 ≥ 803.62 \[2.70--4.87\]\< 0.0015.05 \[3.58--7.12\]\< 0.001Female0.94 \[0.82--1.08\]0.3970.69 \[0.58--0.82\]\< 0.001Extracardiac arteriopathy1.42 \[1.17--1.73\]\< 0.0011.18 \[0.94--1.47\]0.157Renal impairment4.06 \[2.50--6.58\]\< 0.0012.37 \[1.37--4.08\]0.002Chronic lung disease1.28 \[1.10--1.48\]\< 0.0011.00 \[0.84--1.18\]0.980Hypertension1.27 \[1.10--1.48\]0.0010.94 \[0.78--1.13\]0.520Hyperlipidemia1.18 \[1.01--1.38\]0.0481.02 \[0.83--1.24\]0.882Diabetes1.39 \[1.09--1.77\]0.0081.01 \[0.76--1.33\]0.957Angina pectoris1.20 \[1.02--1.42\]0.0301.00 \[0.82--1.22\]0.994Recent MI1.50 \[0.92--2.43\]0.1011.14 \[0.66--1.95\]0.643History of PCI2.61 \[1.46--4.66\]0.0011.76 \[0.90--3.44\]0.101Congestive heart failure1.37 \[1.08--1.74\]0.0101.09 \[0.83--1.44\]0.527Emergent surgery1.78 \[1.31--2.43\]\< 0.0011.50 \[1.05--2.13\]0.026Atrial fibrillation1.34 \[0.98--1.83\]0.0691.08 \[0.76--1.54\]0.655Perioperative RBC Transfusion 0--1 unitsReferenceReference 2--3 units2.01 \[1.21--3.34\]0.0071.56 \[0.93--2.63\]0.092 4--5 units4.09 \[2.46--6.80\]\< 0.0012.89 \[1.71--4.87\]\< 0.001 ≥ 6 units13.31 \[8.03--22.08\]\< 0.0019.15 \[5.43--15.42\]\< 0.001Surgery site Ascending aortaReferenceReference Aortic arch1.98 \[1.49--2.62\]\< 0.0011.63 \[1.19--2.23\]0.002 Descending thoracic aorta1.20 \[0.98--1.46\]0.0741.36 \[1.07--1.72\]0.011 Combined1.04 \[0.87--1.24\]0.6751.20 \[0.98--1.47\]0.075Surgery year0.97 \[0.94--1.00\]0.0570.96 \[0.93--0.99\]0.015*CI* Confidence interval, *MI* Myocardial infarction, *OR* Odds ratio, *PCI* Percutaneous coronary intervention, *RBC* Red blood cell

Cumulative all-cause mortality {#Sec8}
------------------------------

The results of Cox regression for cumulative all-cause mortality are presented in Table [4](#Tab4){ref-type="table"}. The median (interquartile range) duration of follow-up after surgery was 3.1 (1.3--5.7) years. Low and medium volume centers were combined for the Cox regression analysis because the proportional hazards assumption was not met between the two groups. Patients who underwent thoracic aorta replacement surgery in low or medium volume centers showed a significantly higher risk of cumulative all-cause mortality compared to patients in high volume centers (adjusted hazard ratio, 1.55; 95% CI, 1.38--1.74; *P* \< 0.001) (Table [4](#Tab4){ref-type="table"}). The Kaplan-Meier survival curves with a follow-up period of up to 9 years showed a similar pattern (log-rank test, *P* \< 0.001; Fig. [2](#Fig2){ref-type="fig"}). Table 4Cox proportional hazard model for cumulative all-cause mortality after thoracic aorta replacement surgeryUnivariable modelMultivariable modelHR (95% CI)*P*HR (95% CI)*P*Case volume strata High volume (\> 60 cases/year)ReferenceReference Low & medium volume (≤60 cases/year)^a^1.53 (1.37--1.70)\< 0.0011.55 (1.38--1.74)\< 0.001Age ≤ 49ReferenceReference 50--591.23 (0.98--1.53)0.0701.27 (1.02--1.58)0.036 60--691.80 (1.49--2.18)\< 0.0011.87 (1.54--2.28)\< 0.001 70--793.08 (2.58--3.67)\< 0.0013.24 (2.67--3.93)\< 0.001 ≥ 804.22 (3.39--5.25)\< 0.0014.70 (3.73--5.93)\< 0.001Female0.97 (0.88--1.08)0.6210.73 (0.65--0.82)\< 0.001Extracardiac arteriopathy1.43 (1.24--1.65)\< 0.0011.15 (1.00--1.33)0.058Renal impairment3.02 (2.23--4.09)\< 0.0011.89 (1.39--2.58)\< 0.001Chronic lung disease1.34 (1.20--1.49)\< 0.0011.02 (0.91--1.14)0.701Hypertension1.29 (1.16--1.44)\< 0.0010.94 (0.83--1.06)0.320Hyperlipidemia1.25 (1.11--1.41)\< 0.0011.01 (0.89--1.15)0.896Diabetes1.49 (1.25--1.76)\< 0.0011.07 (0.90--1.28)0.448Angina pectoris1.23 (1.09--1.39)0.0010.99 (0.87--1.13)0.852Recent MI1.43 (1.02--2.01)0.0401.22 (0.86--1.73)0.269History of PCI1.94 (1.28--2.93)0.0021.05 (0.68--1.61)0.829Congestive heart failure1.44 (1.22--1.70)\< 0.0011.17 (0.98--1.40)0.081Emergent surgery1.35 (1.07--1.71)0.0121.37 (1.07--1.75)0.012Atrial fibrillation1.45 (1.17--1.81)0.0011.17 (0.93--1.46)0.178Perioperative RBC Transfusion 0--1 unitsReferenceReference 2--3 units2.32 (1.56--3.44)\< 0.0011.80 (1.21--2.67)0.004 4--5 units3.76 (2.52--5.59)\< 0.0012.74 (1.83--4.08)\< 0.001 6- units9.02 (6.09--13.37)\< 0.0015.95 (4.00--8.85)\< 0.001Surgery site Ascending aortaReferenceReference Aortic arch1.72 (1.41--2.09)\< 0.0011.46 (1.20--1.79)\< 0.001 Descending thoracic aorta1.10 (0.95--1.27)0.1931.25 (1.06--1.46)0.006 Combined1.02 (0.90--1.16)0.7601.08 (0.94--1.23)0.287*CI* Confidence interval, *HR* Hazard ratio, *MI* Myocardial infarction, *PCI* Percutaneous coronary intervention, *RBC* Red blood cell^a^Low- and medium-volume groups were merged into one group prior to the multivariable analysis to meet the proportional hazard assumptionFig. 2Kaplan-Meier curves of cumulative all-cause mortality after thoracic aorta replacement according to institutional case volume. The shaded area refers to 95% confidence interval

Discussion {#Sec9}
==========

In this nationwide population-based study, low institutional case volume was an independent risk factor of mortality following thoracic aorta replacement surgery. The risk of in-hospital mortality was significantly higher in patients who underwent surgery in low (\< 30 cases/year) and medium volume centers (30--60 cases/year), compared to high volume centers (\> 60 cases/year). One year and cumulative all-cause mortality rates were both similarly higher in centers with low volume.

First described in the aircraft industry \[[@CR14]\], the positive relationship between higher institutional case volume and improved patient survival have been consistently and repeatedly shown in high risk complex surgical procedures such as hepatectomy \[[@CR4]\], esophagectomy \[[@CR4], [@CR5]\], lung resection \[[@CR5], [@CR15]\], and pelvic exenteration \[[@CR4]\]. Thoracic aorta surgery is also a high-risk surgical procedure which requires complex and skilled surgical technique and immaculate perioperative care for best possible outcome. The reported incidence of operative mortality and major complications including stroke, infection, and renal failure following emergent surgical repair of acute thoracic or thoracoabdominal aortic dissection are exceptionally high, often exceeding 20 and 70%, respectively \[[@CR16]\].

Numerous studies in cardiac surgery have shown that the risk of postoperative death was lower in high volume centers compared to lower volume centers including coronary artery bypass grafting \[[@CR7]\], aortic valve replacement \[[@CR17]\], mitral valve procedures \[[@CR18]\], aortic root replacement \[[@CR19]\], and heart transplantation \[[@CR2]\]. A similar volume-outcome relationship have been reported in urgent or emergent abdominal aorta surgery \[[@CR16], [@CR20]\], but the relationship was between surgeon case volume, not institutional case volume, and patients outcome. The suggested cutoff was 10 ruptured abdominal aorta repairs and interestingly, there was no relationship between center volume and mortality \[[@CR20]\]. Similarly, a previous national study in the United States revealed that the risk of mortality after emergent repair of thoracic or thoracoabdominal aortic dissection doubled in patients operated on by lower volume surgeons and centers (first quartile) compared to the highest volume surgeons \[[@CR16]\]. The inverse association between institutional case volume and postoperative mortality was also noted in elective aortic root replacement surgery \[[@CR19]\]. Our study included all types of thoracic aorta surgery and showed that the risk of postoperative death decreased significantly as institutional case volume increased.

Regionalization in the medical field is an attempt to concentrate resources to a few specialized health care centers /providers, often with an aim to improve patient outcome \[[@CR21]\]. With a few exceptions such as in bariatric surgery \[[@CR22]\], the literature in general tends to favor regionalization as shown in neonatal intensive care units \[[@CR23]\] and designated pediatric trauma centers \[[@CR24]\]. One recent relevant example may be the study which showed profound survival benefit in patients with influenza A-related (H1N1) acute respiratory distress syndrome after transfer to centers capable and experienced in extracorporeal membrane oxygenation \[[@CR25]\]. A downside of regionalization may be decreased accessibility as shown in a simulated regionalization in pediatric cardiac surgery in the United States by closure of low volume hospitals which reduced postoperative mortality \[[@CR26], [@CR27]\]. Considering that previous studies were mostly performed in large countries, regionalization or concentration of high-risk cardiovascular surgeries to a limited number of select centers may be very effective for outcome optimization especially in relatively smaller countries where decreased geographical accessibility is negligible.

There are several limitations in our study that should be considered. First, although all cases of adult thoracic aorta replacement surgery performed during the past 8 years in Korea was included, bias may have been introduced due to the retrospective nature of the study design. Second, potential confounders such as laboratory data or clinical variables could not be obtained since the NHIS database was an administrative database in nature. Third, the information on the severity of thoracic aorta disease was lacking and may have affected postoperative patient outcome. Although a study suggested that the surgical indication for aorta surgery (dissection/ruptured aneurysm vs. intact aneurysms) had little effect on long-term mortality for 30-day survivors \[[@CR28]\], another study suggested that in-hospital mortality seems to be worse in patients with ruptured thoracic aortic aneurysms compared to patients with intact thoracic aortic aneurysms \[[@CR29]\]. Fourth, individual surgeon volume was not analyzed. Considering that most centers in Korea, including high volume centers, have a very limited number of surgeons who perform thoracic aorta surgery, the impact of institutional case volume on surgical outcomes may be comparable to that of surgeon volume.

Conclusions {#Sec10}
===========

In conclusion, patients who underwent thoracic aorta replacement surgery in lower volume centers had significantly higher risk of in-hospital, 1-year, and cumulative all-cause mortality compared to patients in higher volume centers. However, considering the emergent nature of some thoracic aorta replacement surgeries and the different accessibility to institutions competent of performing the surgery, factors other than case volume should be considered when interpreting our results.

CI

:   Confidence interval

ICD-10

:   International Classification of Diseases 10th revision

NHIS

:   National Health Insurance Service

OR

:   Odds ratio
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